ArticleBMC pulmonary medicine2020

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3).

Dirk-Jan Slebos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.